Congratulations to the 2013 Rx-360 Board of Directors.  The new positions, in red below, become effective  January 1, 2013:

Chair: 
Al Kentrup, Sandoz

Vice Chair: 
Brian Johnson, Pfizer 

Treasurer:
Martin VanTrieste, Amgen

Supplier Board Members: 

• Alan Burns, Sartorius
• Hubertus Folttmann, BASF
• Frithjof Holtz, Merck KGaA 
• Guy Villax, Hovione
  

Finished Product Board Manufacturer Members: 

• Tom Beil, Sigma Aldrich
• Janice Berger, AstraZeneca
• Janice Berman, Takeda
• Lynne Byers, GSK
• Thomas Crispin, Bayer
• Heike Falkenhagen, Boehringer Ingelheim
• Joseph Famulare, Genentech
• Jaspret Gill, Baxter
• Teri Hall, Merck
• Patricia Latzo, Mylan
• Mark Paviglianti, Merck
• Elizabeth Pileggi, Teva
• Wes Schmidt, Abbott/AbbVie 
• Melissa Seymour, Biogen Idec   
  

A special thank you to those members who are finishing up their term:

• Jack Brinnier, Watson
• Burghard Freiberg, Merck KGaA
• Diane Petitti, BMS
• Paul Smaltz, Avantor